Skip to main content
Clinical Trials/NCT01841879
NCT01841879CompletedNot Applicable

Mumbai Worksite Tobacco Control Study

Harvard School of Public Health (HSPH)1 site in 1 country6,880 target enrollmentStarted: June 1, 2010Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
6,880
Locations
1
Primary Endpoint
Tobacco use cessation

Study Overview

Brief Summary

The investigators are designing and testing the effectiveness of an integrated tobacco control and occupational health (OH) intervention aimed at promoting tobacco cessation among workers and supporting the adoption, implementation, and enforcement of tobacco control policies in 20 manufacturing worksites in the greater Mumbai region of India.

Detailed Description

Through 6 health education events at the worksites, blue-collar workers (who face dual health risks through their exposures to occupational hazards and their high rates of tobacco use) will gain the knowledge, skills, and social support needed to quit tobacco use.

Simultaneously, management will receive OH and tobacco policy consultations to help build a healthy and safe work environment, where workers' hazardous exposures are reduced.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Prevention
Masking
None

Eligibility Criteria

Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • Manufacturing worksites located in the Mumbai, Thane, or Raigad districts of India
  • Employ at least 60% production workers/40% administrative staff OR at employ at least 200 production workers on staff. NOTE: We are defining "workers" as anyone who is on the company roster, regardless of whether they're permanent or contractual
  • Companies must be autonomous decision-makers and allow us to function at their worksite
  • Companies must be willing to provide us with a current employee roster

Exclusion Criteria

  • Employees do not speak English, Hindi, or Marathi

Outcomes

Primary Outcomes

Tobacco use cessation

Time Frame: 6-month post intervention

Secondary Outcomes

  • Changes in company tobacco policy(6-month post intervention)

Investigators

Sponsor
Harvard School of Public Health (HSPH)
Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Glorian Sorensen

Professor of Society, Human Development, and Health

Harvard School of Public Health (HSPH)

Study Sites (1)

Loading locations...

Similar Trials